5:34 PM
 | 
Oct 18, 2011
 |  BC Extra  |  Top Story

Servier, miRagen in cardiovascular deal

Servier (Neuilly-sur-Seine, France) partnered with miRagen Therapeutics Inc. (Boulder, Colo.) to develop and commercialize microRNA-targeting products for cardiovascular disease. The deal includes miRagen's preclinical programs targeting microRNA-208 (miR-208) and miR-15/195, as well as a...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >